Ironwood Pharmaceuticals, Inc. Class A
Head Quarters
4th floor 301 Binney Street USWebsite
http://www.ironwoodpharma.comIndustry
PharmaceuticalsOtherEmployees
674Exchange
NASDAQIronwood Pharmaceuticals, Inc. is a pharmaceutical company. It discovers, develops and intends to commercialize differentiated medicines that improve patient's lives. Its products include linaclotide, a guanylate cyclase type-C agonist being developed for the treatment of patients with irritable bowel syndrome with constipation and chronic constipation. The company was founded by Peter M. Hecht, Eric F. Summers, G. Todd Milne, Brian M. Cali, Joseph C. Cook, Jr. and Gina Bornino Miller on January 5, 1998 and is headquartered in Cambridge, MA.
Key statistics
Margins | Stock |
---|---|
Revenue per Employee | $0.00 |
Current Ratio | 4 |
Gross Margin (%) | 0.94% |
Net Margin (%) | -0.20% |
Returns | Stock |
Sales | $260.00M |
Sales Growth (% qtr vs. yr ago) | 0.00% |
Net Income | -$27.00M |
NI Growth (% qtr vs. yr ago) | 0.00% |
Price/Sales | 22.08 |
EPS | $0.00 |